| EDITORIALS | 5 |
| REVIEWS | 6 |
| Hypertension guidelines for type 2 diabetes in South Africa: consensus and controversies | 6 |
| Cardiovascular disease and diabetes in people with severe mental illness: causes, consequences and pragmatic management | 9 |
| Diabetes and the metabolic syndrome in HIV | 14 |
| The effects of medicinal plants on renal function and blood pressure in diabetes mellitus | 16 |
| DIABETES EDUCATOR'S FOCUS | 22 |
| DIABETES PERSONALITY | 22 |
| EVIDENCE IN PRACTICE | 27 |
| REPORT | 30 |
| ADA Watch, 2012 update from Philadelphia, USA | 30 |
| 22nd European meeting on hypertension and cardiovascular protection, London 2012 | 36 |
| Southern African Hypertension Society congress report, March 2012 The young hypertensive | 37 |
| Southern African Hypertension Society congress report, March 2012 Management of type 2 diabetes in primary healthcare | 38 |
| Management of type 2 diabetes in primary healthcare | 38 |
| DRUG TRENDS | 39 |
| ORIGIN trial shows safety and efficacy of insulin glargine: no adverse cardiovascular outcomes after a 6.2-year follow up of early insulin use | 39 |
| Managing neuropathic pain: first expert recommendation for South Africa places emphasis on stepwise pharmacological intervention | 43 |
| Saxagliptin efficacy and safety in special patient groups (the elderly and those with renal impairment) | 46 |